BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 32811531)

  • 1. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
    Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
    Zhang Y; Ding J; Ren S; Wang W; Yang Y; Li S; Meng M; Wu T; Liu D; Tian S; Tian H; Chen S; Zhou C
    Stem Cell Res Ther; 2020 May; 11(1):207. PubMed ID: 32460839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
    Shi L; Zheng Y; Cheng Z; Ji N; Niu C; Wang Y; Huang T; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2022 Jul; 13(1):321. PubMed ID: 35842684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
    Feng G; Shi L; Huang T; Ji N; Zheng Y; Lin H; Niu C; Wang Y; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J
    Stem Cells Dev; 2021 Aug; 30(15):773-781. PubMed ID: 34044609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
    Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
    Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Transplantation Therapy: A Potential Method for Treating Cytokine Storm Syndromes Induced by COVID-19.
    Wang HC; Wang X; Long X
    Cell Transplant; 2020; 29():963689720965980. PubMed ID: 33040594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.
    Tang L; Jiang Y; Zhu M; Chen L; Zhou X; Zhou C; Ye P; Chen X; Wang B; Xu Z; Zhang Q; Xu X; Gao H; Wu X; Li D; Jiang W; Qu J; Xiang C; Li L
    Front Med; 2020 Oct; 14(5):664-673. PubMed ID: 32761491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
    Sengupta V; Sengupta S; Lazo A; Woods P; Nolan A; Bremer N
    Stem Cells Dev; 2020 Jun; 29(12):747-754. PubMed ID: 32380908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.
    Guo Z; Chen Y; Luo X; He X; Zhang Y; Wang J
    Crit Care; 2020 Jul; 24(1):420. PubMed ID: 32653043
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
    Shi X; Yu L; Ding C
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell research progress for the treatment of COVID-19.
    Yao D; Ye H; Huo Z; Wu L; Wei S
    J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
    Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
    Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
    Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient.
    Tao J; Nie Y; Wu H; Cheng L; Qiu Y; Fu J; Jiang X
    J Infect Dev Ctries; 2020 Oct; 14(10):1138-1145. PubMed ID: 33175709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.